No business profile yet.
Size Avacta (AVCT.L) is a United Kingdom Industrials company (Miscellaneous Commercial Services) with a market value of $363M, the 330th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £56.80 on 18 Nov 2026.
Performance Over six months the shares fell 32.8%, against -25.6% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 8th lowest of 21 in its peer set.
Growth Revenue fell 99.5% over the last twelve months (peer median +5.7%); the operating margin is -27,388.5% (peer median 3.1%).
Valuation It trades at 65.89× book value against a peer median of 1.90× (most expensive of 21).
Price implies The share price implies a return on equity of about 614.1%; Avacta delivers -2,001.2%, so the price asks more than the business earns today.
Next results Next results expected around 22 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | £113,000 | £113,000 | £113,000 | £2.85M | £9.65M |
| Revenue growth | — | 0% | -96% | -70% | — |
| Gross profit | -£990,000 | -£1.17M | -£1.39M | £1.54M | £4.23M |
| EBITDA | -£29.8M | -£29.0M | -£30.2M | -£20.7M | -£22.5M |
| Net income | -£40.4M | -£38.4M | -£52.8M | -£33.3M | -£36.9M |
| Free cash flow | -£27.6M | -£26.8M | -£23.9M | -£15.1M | -£17.0M |
| Capital expenditure | £33,000 | £53,000 | £339,000 | £205,000 | £594,000 |
| Total debt | n/a | £17.7M | £24.2M | £46.7M | £62.9M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | AVCT.L | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -16.8% | -10.8% | 8th lowest of 21 |
| 6-month return | -32.8% | -25.6% | 8th lowest of 21 |
| Return on equity | -2,001.2% | 1.6% | lowest of 21 |
| Price / book | 65.89× | 1.90× | most expensive of 21 |
| ROE the price implies | 614.1% | 20.1% | most demanding of 21 |
| ROE delivered | -2,001.2% | 1.6% | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| Avacta AVCT.L | United Kingdom | $363M | -33% | -100% | -2,001% | 65.89× | 614.1% | -2,001.2% |
| Pubang Landscape Architecture 002663.SZ | China | $364M | -36% | -25% | -21% | 1.28× | 10.0% | -20.9% |
| Suzhou Kelida Building & Decoration 603828.SS | China | $365M | -29% | -49% | -36% | 5.56× | 20.1% | -35.9% |
| YingTong Telecommunication 002861.SZ | China | $362M | -23% | +15% | -10% | 2.48× | 15.7% | -10.2% |
| K-Bro Linen KBL.TO | Canada | $361M | -1% | +31% | 9% | 1.79× | 10.2% | 8.8% |
| AbClon 174900.KS | South Korea | $360M | -40% | +45% | -66% | 19.79× | 94.2% | -66.2% |
| SMO ClinPlus 301257.SZ | China | $359M | -35% | 0% | 2% | 1.88× | 23.3% | 2.4% |
| RattanIndia Enterprises RTNINDIA.NS | India | $359M | -28% | -3% | -31% | 4.39× | 71.8% | -31.3% |
| Hebei Gongda Keya Technology 301197.SZ | China | $369M | -45% | -4% | 0% | 1.91× | 21.9% | -0.1% |
| TECSYS TCS.TO | Canada | $369M | +2% | +10% | 10% | 8.56× | 39.1% | 9.7% |
| Shenzhen Jiang & Associates Creative Design 300668.SZ | China | $369M | -65% | -37% | -1% | 3.11× | 20.2% | -0.8% |
| Beijing Kaiwen Education Technology 002659.SZ | China | $357M | -19% | +7% | -1% | 1.11× | 10.1% | -0.7% |
| Brunel International BRNL.AS | Netherlands | $371M | -11% | -6% | 3% | 1.28× | 6.8% | 3.0% |
| Hargreaves Services HSP.L | United Kingdom | $355M | +10% | +33% | 16% | 1.37× | 11.9% | 15.7% |
| Skytech 6937.TW | Taiwan | $376M | -32% | +14% | 10% | 3.36× | 22.0% | 10.4% |
| Materials Analysis Technology 3587.TWO | Taiwan | $350M | -53% | +4% | 8% | 1.84× | 14.8% | 8.3% |
| Tera Probe 6627.T | Japan | $377M | -43% | +44% | 14% | 1.35× | 23.9% | 14.4% |
| Takara & 7921.T | Japan | $350M | +27% | +4% | 11% | 1.64× | 6.1% | 11.4% |
| Roma Green Finance ROMA | United States | $378M | -5% | -22% | -44% | 39.56× | 473.8% | -44.2% |
| Optima Health OPT.L | United Kingdom | $349M | +29% | +15% | 1% | 1.28× | 8.1% | 0.8% |
| Medley 4480.T | Japan | $349M | -16% | +21% | 10% | 3.46× | 28.5% | 10.4% |